Cargando…

Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease

BACKGROUND: While the association of the prevalence of non-alcoholic fatty liver disease (NAFLD) with impaired glucose metabolism has been reported, the factors influencing glucose tolerance in NAFLD remain to be clarified. METHODS: Glucose tolerance of 131 Japanese patients diagnosed as NAFLD by hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohmi, Satoko, Ono, Masafumi, Takata, Hiroshi, Hirano, Seiki, Funakoshi, Shogo, Nishi, Yuichi, Yoshimura, Kumiko, Amano, Eri, Terada, Yoshio, Saibara, Toshiji, Fujimoto, Shimpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584018/
https://www.ncbi.nlm.nih.gov/pubmed/28878826
http://dx.doi.org/10.1186/s13098-017-0264-7
_version_ 1783261392851173376
author Ohmi, Satoko
Ono, Masafumi
Takata, Hiroshi
Hirano, Seiki
Funakoshi, Shogo
Nishi, Yuichi
Yoshimura, Kumiko
Amano, Eri
Terada, Yoshio
Saibara, Toshiji
Fujimoto, Shimpei
author_facet Ohmi, Satoko
Ono, Masafumi
Takata, Hiroshi
Hirano, Seiki
Funakoshi, Shogo
Nishi, Yuichi
Yoshimura, Kumiko
Amano, Eri
Terada, Yoshio
Saibara, Toshiji
Fujimoto, Shimpei
author_sort Ohmi, Satoko
collection PubMed
description BACKGROUND: While the association of the prevalence of non-alcoholic fatty liver disease (NAFLD) with impaired glucose metabolism has been reported, the factors influencing glucose tolerance in NAFLD remain to be clarified. METHODS: Glucose tolerance of 131 Japanese patients diagnosed as NAFLD by histological findings of liver biopsy specimen was examined using 75 g-OGTT. According to Matteoni’s classification, patients were divided to 4 groups [M1 ~ 4, M1, 2: non-alcoholic fatty liver (NAFL); and M3, 4: non-alcoholic steatohepatitis (NASH)]. Based on the OGTT data, insulinogenic index (IGI) and QUICKI were calculated as indices of insulin secretion and insulin sensitivity, respectively. Plasma glucose 120 min after glucose loading (G(120)) was used as the index for glucose intolerance. RESULTS: Stepwise multiple regression analysis using G(120) as a dependent variable and log(e)-IGI, QUICKI, sex, BMI, age, NAFL/NASH as independent variables revealed that log(e)-IGI (β = −0.595) and QUICKI (β = −0.323) are significant factors predicting glucose intolerance (R(2) = 0.403), indicating an important role of insulin secretion in glucose tolerance. These findings accord with glucose intolerance as high as 89.7% in patients with impaired insulin secretion defined by ≤43.2 pmol/mmol (40 μU/mg) IGI. Stepwise multiple regression analysis using QUICKI as a dependent variable and NAFL/NAFLD, sex, BMI, and age as independent variables revealed that BMI (β = −0.469) and NAFL/NAFLD (β = −0.204) are significant factors predicting insulin sensitivity (R(2) = 0.248). CONCLUSION: Impairment of insulin secretion is the most important factor to predict glucose intolerance in NAFLD; severity of histological findings is associated with insulin sensitivity independent of adiposity in NAFLD.
format Online
Article
Text
id pubmed-5584018
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55840182017-09-06 Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease Ohmi, Satoko Ono, Masafumi Takata, Hiroshi Hirano, Seiki Funakoshi, Shogo Nishi, Yuichi Yoshimura, Kumiko Amano, Eri Terada, Yoshio Saibara, Toshiji Fujimoto, Shimpei Diabetol Metab Syndr Research BACKGROUND: While the association of the prevalence of non-alcoholic fatty liver disease (NAFLD) with impaired glucose metabolism has been reported, the factors influencing glucose tolerance in NAFLD remain to be clarified. METHODS: Glucose tolerance of 131 Japanese patients diagnosed as NAFLD by histological findings of liver biopsy specimen was examined using 75 g-OGTT. According to Matteoni’s classification, patients were divided to 4 groups [M1 ~ 4, M1, 2: non-alcoholic fatty liver (NAFL); and M3, 4: non-alcoholic steatohepatitis (NASH)]. Based on the OGTT data, insulinogenic index (IGI) and QUICKI were calculated as indices of insulin secretion and insulin sensitivity, respectively. Plasma glucose 120 min after glucose loading (G(120)) was used as the index for glucose intolerance. RESULTS: Stepwise multiple regression analysis using G(120) as a dependent variable and log(e)-IGI, QUICKI, sex, BMI, age, NAFL/NASH as independent variables revealed that log(e)-IGI (β = −0.595) and QUICKI (β = −0.323) are significant factors predicting glucose intolerance (R(2) = 0.403), indicating an important role of insulin secretion in glucose tolerance. These findings accord with glucose intolerance as high as 89.7% in patients with impaired insulin secretion defined by ≤43.2 pmol/mmol (40 μU/mg) IGI. Stepwise multiple regression analysis using QUICKI as a dependent variable and NAFL/NAFLD, sex, BMI, and age as independent variables revealed that BMI (β = −0.469) and NAFL/NAFLD (β = −0.204) are significant factors predicting insulin sensitivity (R(2) = 0.248). CONCLUSION: Impairment of insulin secretion is the most important factor to predict glucose intolerance in NAFLD; severity of histological findings is associated with insulin sensitivity independent of adiposity in NAFLD. BioMed Central 2017-09-05 /pmc/articles/PMC5584018/ /pubmed/28878826 http://dx.doi.org/10.1186/s13098-017-0264-7 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ohmi, Satoko
Ono, Masafumi
Takata, Hiroshi
Hirano, Seiki
Funakoshi, Shogo
Nishi, Yuichi
Yoshimura, Kumiko
Amano, Eri
Terada, Yoshio
Saibara, Toshiji
Fujimoto, Shimpei
Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
title Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
title_full Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
title_fullStr Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
title_full_unstemmed Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
title_short Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
title_sort analysis of factors influencing glucose tolerance in japanese patients with non-alcoholic fatty liver disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584018/
https://www.ncbi.nlm.nih.gov/pubmed/28878826
http://dx.doi.org/10.1186/s13098-017-0264-7
work_keys_str_mv AT ohmisatoko analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT onomasafumi analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT takatahiroshi analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT hiranoseiki analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT funakoshishogo analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT nishiyuichi analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT yoshimurakumiko analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT amanoeri analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT teradayoshio analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT saibaratoshiji analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease
AT fujimotoshimpei analysisoffactorsinfluencingglucosetoleranceinjapanesepatientswithnonalcoholicfattyliverdisease